Aldeyra Therapeutics, Inc. (ALDX) sees insider buying from three insiders: $140,275
The largest purchase: $128,900 by Richard Douglas, a director. Information only, not investment advice.
Form 4 filings show three Aldeyra Therapeutics, Inc. insiders buying stock between Nov 11 and Nov 12, for a total of $140,275.
Richard Douglas (director) made the largest purchase, $128,900 at an average of $0.6445 a share. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.
Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan. The table below lists who bought, when, and at what price.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Richard Douglas | Director | Nov 11 | 200,000 | $0.6445 | $128,900 | App · SEC |
| Michael Alfieri | Principal Financial Officer | Nov 11 | 10,000 | $0.6500 | $6,500 | App · SEC |
| Darlene M Deptula-Hicks | Director | Nov 12 | 7,500 | $0.6500 | $4,875 | App · SEC |
| Total | $140,275 |
Each row of the table links to its Form 4 on SEC.gov.
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.